PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer

The tumor recurrence and drug resistance of hepatocellular carcinoma (HCC) threatened patients a lot. The mechanism should be further explored. The information of expression status and survival were available in public databases. The Western blot and immunohistochemistry staining displayed the level...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hanpu, Li, Chenyuan, Liao, Shichong, Tu, Yi, Sun, Shengrong, Yao, Feng, Li, Zhiyu, Wang, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519003/
https://www.ncbi.nlm.nih.gov/pubmed/36137220
http://dx.doi.org/10.1080/15384047.2022.2125260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519003/
https://www.ncbi.nlm.nih.gov/pubmed/36137220
http://dx.doi.org/10.1080/15384047.2022.2125260

Ejemplares similares